Page 1

EX - 99.1 2 d132413dex991.htm EX - 99.1 Walgreens Boots Alliance Press Release Exhibit 99.1 Walgreens Boots Alliance Fiscal 2021 Second Quarter Results Exceed Expectations Company Raises Guidance for Fiscal Year Second quarter results , year - over - year , including discontinued operations Total earnings per share ( EPS ) , including discontinued operations , increased 10.9 percent to $ 1.19 , compared to $ 1.07 in the year - ago quarter ; total adjusted EPS decreased 7.5 percent to $ 1.40 , down 8.2 percent on a constant currency basis Second quarter results , year - over - year , from continuing operations Sales increased 4.6 percent to $ 32.8 billion , up 3.5 percent on a constant currency basis , excluding sales from discontinued operations of $ 4.8 billion EPS from continuing operations increased 8.7 percent to $ 1.06 ; continuing operations adjusted EPS decreased 10.1 percent to $ 1.26 , down 10.8 percent on a constant currency basis , reflecting an estimated adverse COVID - 19 impact of 40 to 45 cents per share Additional highlights Net cash provided by operating activities in the first half of fiscal 2021 was $ 2.6 billion , an increase of $ 72 million compared with the same period a year ago ; Free cash flow was $ 1.9 billion , up $ 85 million year - over - year Walgreens has administered more than 8 million COVID - 19 vaccines to date , including 4 million in March Fiscal 2021 outlook Company raised guidance to mid - to - high single digit growth in constant currency adjusted EPS from both total and continuing operations CEO Transition On March 15 , Rosalind Brewer succeeded Stefano Pessina as the company's chief executive officer and joined the WBA board of directors ; Pessina transitioned to the role of executive chairman of the board $ 6.5 billion divestiture of Alliance Healthcare on schedule to close before the end of fiscal 2021 Financial presentation changes : assets being divested are moved to discontinued operations DEERFIELD , Ill . , March 31 , 2021 - Walgreens Boots Alliance , Inc. ( Nasdaq : WBA ) today announced financial results for the second quarter of fiscal 2021 , which ended Feb. 28 , 2021 . " Overall , we have achieved a good financial quarter with results well ahead of expectations , despite significant impacts from COVID - 19 , and we have raised our full - year EPS guidance . I am optimistic about our ability to drive sustainable , long - term value for our shareholders , while acknowledging that there is still work to be done to stabilize the base business , " said Brewer . “ I will continue to review closely all our initiatives , strategies and opportunities to capitalize fully on the incredible potential in front of us . Our team will move swiftly and decisively to best serve the needs of our patients , customers and communities around the world , at this critical time and beyond . "